14.01.2020 - 20:44 Uhr

Genix Acquires Exclusive Rights to SUCANON and RENOCHLOR

Genix Pharmaceuticals Corp., CA37232A1093

DGAP-News: Genix Pharmaceuticals Corp.

/ Key word(s): Miscellaneous

Genix Acquires Exclusive Rights to SUCANON(R) and RENOCHLOR(R)

14.01.2020 / 20:42

The issuer is solely responsible for the content of this announcement.

14.01.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Genix Pharmaceuticals Corp.

Canada ISIN: CA37232A1093 EQS News ID: 953583   End of News DGAP News Service

953583  14.01.2020